These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2126688)

  • 1. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.
    Fukuda H; Hosaka M; Hirai K; Iyobe S
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1757-61. PubMed ID: 2126688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Hirai K; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):582-6. PubMed ID: 3111356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.
    Fukuda H; Hosaka M; Iyobe S; Gotoh N; Nishino T; Hirai K
    Antimicrob Agents Chemother; 1995 Mar; 39(3):790-2. PubMed ID: 7793896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.
    Li XZ; Livermore DM; Nikaido H
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1732-41. PubMed ID: 7986003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of a DNA fragment that complements the nfxB mutation in Pseudomonas aeruginosa PAO.
    Okazaki T; Iyobe S; Hashimoto H; Hirai K
    FEMS Microbiol Lett; 1991 Mar; 63(1):31-5. PubMed ID: 1904383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Chamberland S; Bayer AS; Schollaardt T; Wong SA; Bryan LE
    Antimicrob Agents Chemother; 1989 May; 33(5):624-34. PubMed ID: 2502066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem resistance in Pseudomonas aeruginosa.
    Sumita Y; Fukasawa M
    Chemotherapy; 1996; 42(1):47-56. PubMed ID: 8751266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ.
    Hosaka M; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1731-5. PubMed ID: 7486910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa.
    Maseda H; Saito K; Nakajima A; Nakae T
    FEMS Microbiol Lett; 2000 Nov; 192(1):107-12. PubMed ID: 11040437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa.
    Hamzehpour MM; Pechere JC; Plesiat P; Köhler T
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2392-6. PubMed ID: 8585714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem resistance in pseudomonas aeruginosa PAO: mapping of the OprD2 gene.
    Quinn JP; Darzins A; Miyashiro D; Ripp S; Miller RV
    Antimicrob Agents Chemother; 1991 Apr; 35(4):753-5. PubMed ID: 1906263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
    Daikos GL; Lolans VT; Jackson GG
    Antimicrob Agents Chemother; 1988 May; 32(5):785-7. PubMed ID: 3134852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
    Jakics EB; Iyobe S; Hirai K; Fukuda H; Hashimoto H
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2562-5. PubMed ID: 1489207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.
    Maseda H; Yoneyama H; Nakae T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):658-64. PubMed ID: 10681335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN.
    Westfall LW; Carty NL; Layland N; Kuan P; Colmer-Hamood JA; Hamood AN
    FEMS Microbiol Lett; 2006 Feb; 255(2):247-54. PubMed ID: 16448502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S
    Antimicrob Agents Chemother; 1995 Mar; 39(3):645-9. PubMed ID: 7793866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.
    Piddock LJ; Hall MC; Bellido F; Bains M; Hancock RE
    Antimicrob Agents Chemother; 1992 May; 36(5):1057-61. PubMed ID: 1510393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa.
    Michéa-Hamzehpour M; Furet YX; Pechère JC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2091-7. PubMed ID: 1662023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.
    Young M; Hancock RE
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2365-9. PubMed ID: 1336943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.